(17.06.2020)

Israel will receive a donation of Remdesivir, an experimental antiviral drug for COVID-19, from its U.S. manufacturer, Israel‘s prime minister‘s office said on Tuesday.

The Israeli cabinet approved in a telephone vote the decision by the Health Ministry to issue a permit to accept a donation of the drug from Gilead Sciences Inc, the U.S. biopharmaceutical company that produces the drug.